Public Company News

BlackBerry Appoints John Giamatteo as CEO

Company to Pursue Full Separation of IoT and Cybersecurity Business Units * Industry veteran Giamatteo to lead BlackBerry as Chief Executive Officer * IoT and Cybersecurity business units to become fully standalone BlackBerry divisions * Process underway to separate centralized functions and...

2023-12-11 21:00 4701

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"),...

2023-12-11 21:00 3526

WiMi Developed Holographic Complex Amplitude Computation and Update Technology

BEIJING, Dec. 11, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it successfully developed a new technology----"Holographic Complex Amplitude Computation and Updat...

2023-12-11 21:00 2858

China Literature to Acquire Tencent Animation and Comics

HONG KONG, Dec. 11, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual property ("IP") incubation platform inChina, today announced that it has entered into an Asset Transfer Agreement withTencent Hol...

2023-12-11 20:07 5605

HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors

WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to...

2023-12-11 20:00 2808

Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (CDE) of the National Medical Products Administration for the "A Randomized, Open-label, Controlled, Mu...

2023-12-11 20:00 2159

First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent

MELBOURNE, Australia and INDIANAPOLIS, Dec. 11, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in aUnited States (U.S.) expanded access program (EAP, ClinicalTrials.gov ID:NCT06090331

2023-12-11 19:40 2718

2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results

-     A multi-center phase Ib/III study in China and the United States led by ProfessorBinghe Xu, MD, PhD, Academician of the Chinese Academy of Engineering -     70% of the patients enrolled in phase Ib study were previously treated with CDK4/6 inhibitors  -     Demonstrated a confirmed objecti...

2023-12-11 18:55 2446

Ponsse manufactures its 20,000th forest machine

VIEREMÄ, Finland, Dec. 11, 2023 /PRNewswire/ -- The 20,000th PONSSE forest machine has been completed at Ponsse's factory in Vieremä,Finland. After the celebration on 11 December, the PONSSE Bear harvester with PONSSE H8 harvester head will go to a Norwegian customer, Lågen Skogsdrift AS. "It's ...

2023-12-11 18:52 2515

Forging the Future: Weichai Power's Global Strategy for Supply Chain Excellence

Strategic Partner Conference Focuses on Innovation and Collaboration in the Evolving Global Supply Chain Landscape HAIKOU, China, Dec. 11, 2023 /PRNewswire/ -- From December 10 to 11, 2023, Weichai Power (HK2338; SZ000338) hosted the Global Supply Chain Strategic Partner Cooperation Conference i...

2023-12-11 18:04 2960

Qudian Inc. Reports Third Quarter 2023 Unaudited Financial Results

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company, today announced its unaudited financial results for the quarter endedSeptember 30, 2023. Third Quarter 2023 Financial Highlights: * Total revenues w...

2023-12-11 18:00 4267

Vinamilk Earns Multiple Accolades in 2023 Brand Rankings, Underlining Its Commitment to Sustainability

HO CHI MINH CITY, Vietnam, Dec. 11, 2023 /PRNewswire/ -- Vinamilk , Vietnam's leading dairy company, has achieved substantial recognition in Brand Finance's Food and Drink 2023 rankings, affirming its position as a global industry leader committed to sustainability...

2023-12-11 15:44 6595

CHiQ Debuts at FIS Ski Jumping World Cup 2023

BERLIN, Dec. 11, 2023 /PRNewswire/ -- On December 9, Klingenthal, Germany, hosted the Men's FIS Ski Jumping World Cup, attracting top international skiers who demonstrated their courage and innovation. In a significant first, CHiQ, Changhong's premium brand known for its smart home appliances, pa...

2023-12-11 15:30 4069

CREAL announces the launch of its Singapore office to accelerate its Japanese real estate offering to investors in Singapore.

SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- CREAL Inc, a leading Japanese real estate investment firm, listed on the Tokyo Stock Exchange (TSE), today announced the launch of itsSingapore subsidiary. CREAL, a leading Japanese real estate investment firm has two key offerings. It's real estate ...

2023-12-11 13:30 3019

Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib

SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a US study ...

2023-12-11 13:30 2257

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety...

2023-12-11 13:14 2273

Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR

SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the clinical data of lisaftocl...

2023-12-11 12:56 1846

ChuanQi IP Launches Teaser Site for

* Blockchain-Based AFK RPG, the Third Title in the 'MIR2M' Series * Party up to 5 Characters for Simultaneous Growth, Hidden Jobs Unveiled upon Reaching Certain Levels * Various Details, Including Pre-Registration Event, to be Revealed Soon SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- C...

2023-12-11 12:00 3594

China Shenhua Included in the List of 2023 Corporate Governance Best Practice Cases

BEIJING, Dec. 11, 2023 /PRNewswire/ -- China Shenhua was recently selected as one of the 2023 Corporate Governance Best Practice Cases by the China Association for Public Companies and included in theChina Listed Company Governance Report. China Shenhua attaches great importance to corporate gov...

2023-12-11 09:10 3238

GCL SI Makes Waves at COP28, Showcasing Strong Commitment to Triple Renewable Energy Capacity

DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ -- The critical 28th United Nations Climate Change Conference, or Conference of Parties(COP28) is currently taking place inDubai, bringing together global leaders and companies to take decisive action against climate change. As a leading renewable energy com...

2023-12-11 09:04 4745